Sandra Li

Title: Innovations by Inventor Sandra Li

Introduction

Sandra Li is a notable inventor based in Dilbeek, Belgium. She has made significant contributions to the field of biotechnology, particularly in cancer treatment. With a total of 2 patents, her work focuses on innovative methods to inhibit tumor growth.

Latest Patents

Sandra Li's latest patents include groundbreaking methods for inhibiting tumor growth or treating cancer by administering an immunoglobulin single variable domain that binds glucocorticoid-induced TNFR family-related receptor (GITR). The inventions relate to immunoglobulin single variable domains that bind GITR, including polypeptides that comprise or essentially consist of these domains. Additionally, her patents cover nucleic acids encoding such polypeptides, methods for preparing them, and pharmaceutical compositions that utilize these polypeptides for prophylactic, therapeutic, or diagnostic purposes. The polypeptides enhance the biological activity of GITR, showcasing their potential in cancer therapies.

Career Highlights

Sandra Li is currently associated with Ablynx N.V., where she continues to advance her research and development efforts. Her work has positioned her as a key figure in the biotechnology sector, contributing to innovative solutions for complex medical challenges.

Collaborations

Some of her notable coworkers include Pieter Deschaght and Veerle Snoeck, who collaborate with her on various projects within the company.

Conclusion

Sandra Li's contributions to cancer treatment through her innovative patents highlight her role as a leading inventor in biotechnology. Her work continues to inspire advancements in medical research and therapeutic applications.